Virtu Financial LLC Makes New $151,000 Investment in SIGA Technologies, Inc. (NASDAQ:SIGA)

Virtu Financial LLC acquired a new stake in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) in the third quarter, Holdings Channel.com reports. The fund acquired 22,299 shares of the company’s stock, valued at approximately $151,000.

Several other large investors have also modified their holdings of SIGA. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of SIGA Technologies by 152.6% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock valued at $13,827,000 after purchasing an additional 1,237,620 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of SIGA Technologies by 251.2% in the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock worth $6,389,000 after buying an additional 602,091 shares during the period. Foundry Partners LLC acquired a new position in shares of SIGA Technologies in the third quarter worth about $2,801,000. Denali Advisors LLC acquired a new position in shares of SIGA Technologies in the second quarter worth about $1,815,000. Finally, Harbor Capital Advisors Inc. purchased a new position in shares of SIGA Technologies in the third quarter worth approximately $1,098,000. 55.40% of the stock is owned by institutional investors.

SIGA Technologies Stock Performance

SIGA Technologies stock opened at $5.73 on Thursday. The company has a 50 day moving average price of $6.79 and a 200 day moving average price of $7.75. SIGA Technologies, Inc. has a 52 week low of $4.26 and a 52 week high of $12.83. The firm has a market capitalization of $409.15 million, a price-to-earnings ratio of 4.78 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA) last issued its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. The company had revenue of $10.01 million for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. Equities analysts forecast that SIGA Technologies, Inc. will post 1.04 earnings per share for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.